BusinessBioMarin Announces Interim Analysis of INSPIRE Clinical Trial in Pompe Disease at 34th Annual J.P. Morgan Annual Healthcare ConferenceBy Nasdaq OMXJan 11, 2016, 4:30 PM UTC